MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
PerkinElmer Total Shareholders Equity 2011-2026 | PKI
Annual Total Shareholders Equity PerkinElmer
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.25 B | 7.67 B | 7.87 B | 7.14 B | 3.74 B | - | 2.81 B | 2.58 B | 2.5 B | 2.11 B | - | 2.04 B | 1.99 B | 1.94 B | 1.93 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.87 B | 1.93 B | 3.97 B |
Quarterly Total Shareholders Equity PerkinElmer
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.38 B | 7.56 B | 7.64 B | 7.67 B | 7.92 B | 7.87 B | 7.85 B | 7.87 B | 7.69 B | 7.87 B | 8.03 B | 7.38 B | 7.07 B | 7.17 B | 7.19 B | 3.74 B | 6.96 B | 4.24 B | 4 B | - | 3.23 B | 2.97 B | 2.76 B | 2.81 B | 2.81 B | 2.81 B | 2.81 B | 2.58 B | 2.58 B | 2.58 B | 2.58 B | 2.5 B | 2.5 B | 2.5 B | 2.5 B | 2.11 B | 2.14 B | 2.09 B | 2.05 B | - | 2.05 B | 2.12 B | 2.06 B | 2.04 B | 2.04 B | 2.04 B | 2.04 B | 1.99 B | 1.99 B | 1.99 B | 1.99 B | 1.94 B | 1.94 B | 1.94 B | 1.94 B | 1.93 B | 1.95 B | 1.96 B | 1.91 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.03 B | 1.91 B | 3.86 B |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.39 B | $ 114.84 | -0.55 % | $ 34.9 B |  USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M |  Israel |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B |  Niderland |
 |
Anixa Biosciences
ANIX
|
15.2 M | $ 2.59 | 1.37 % | $ 84.1 K | USA |
|
Biodesix
BDSX
|
20.9 M | $ 15.32 | 1.66 % | $ 1.99 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.17 | - | $ 4.98 M | USA |
 |
BioNano Genomics
BNGO
|
44.4 M | $ 1.19 | -1.25 % | $ 6.48 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 16.57 | 2.28 % | $ 178 M | China |
 |
CareDx, Inc
CDNA
|
303 M | $ 18.37 | 0.33 % | $ 979 M | USA |
 |
Celcuity
CELC
|
101 M | $ 113.92 | 1.14 % | $ 5.33 B | USA |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 167.82 | -3.49 % | $ 8.32 B | USA |
 |
Castle Biosciences
CSTL
|
456 M | $ 24.95 | 0.44 % | $ 693 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 198.98 | 0.92 % | $ 22.1 B | USA |
 |
Danaher Corporation
DHR
|
52.5 B | $ 191.91 | 0.41 % | $ 137 B | USA |
 |
DexCom
DXCM
|
2.75 B | $ 63.19 | 1.56 % | $ 24.7 B | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 16.66 | -0.95 % | $ 504 M | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 90.61 | -3.44 % | $ 11.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 111.56 | -2.31 % | $ 9.2 B |  Irlanda |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.96 | 5.82 % | $ 8.67 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 128.04 | 0.52 % | $ 20.4 B | USA |
 |
IQVIA Holdings
IQV
|
6.5 B | $ 171.32 | -1.12 % | $ 29.4 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 275.75 | 0.74 % | $ 22.9 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 76.36 | 0.35 % | $ 5.15 B | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 490.0 | -1.67 % | $ 14.1 B | USA |
 |
Organovo Holdings
ONVO
|
10.5 M | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
7.38 M | - | -16.95 % | $ 1.54 M | USA |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 257.33 | -0.21 % | $ 25.9 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.78 | 0.63 % | $ 443 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.26 M | $ 4.51 | -3.84 % | $ 3.55 M | USA |
 |
NeoGenomics
NEO
|
837 M | $ 8.0 | - | $ 1.02 B | USA |